Retour
Fourchette du Jour
70,67 €
73,15 €
Fourchette 52 Semaines
23,95 €
86,74 €
Volume
2 086 619
Moyenne 50J / 200J
79,69 €
/
64,60 €
Clôture Précédente
70,99 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -30,7 | 0,4 |
| P/B | 23,9 | 2,9 |
| ROE % | -70,7 | 3,7 |
| Net Margin % | -40,4 | 3,9 |
| Rev Growth 5Y % | 3,9 | 10,0 |
| D/E | 5,4 | 0,2 |
Objectif de Cours des Analystes
Hold
91,33 €
+29.0%
Low: 65,00 €
High: 103,00 €
BPA Prévisionnel
-3,82 €
CA Est.
830 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
6,11 €
4,73 € – 7,44 €
|
3,5 B | 4 |
| FY2029 |
3,26 €
2,52 € – 3,97 €
|
2,7 B | 4 |
| FY2028 |
0,46 €
-11,68 € – 10,51 €
|
1,9 B | 10 |
Points Clés
Revenue grew 3,89% annually over 5 years — modest growth
Debt/Equity of 5,35 — high leverage
Negative free cash flow of -320,03M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 29,98%
Capital efficient — spends only 5,45% of revenue on capex
Croissance
Revenue Growth (5Y)
3,89%
Revenue (1Y)33,87%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-70,72%
ROIC-9,23%
Net Margin-40,36%
Op. Margin-40,47%
Sécurité
Debt / Equity
5,35
Current Ratio3,83
Interest Coverage-5,23
Valorisation
P/E Ratio
-30,69
P/B Ratio23,91
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 33,87% | Revenue Growth (3Y) | 9,48% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3,89% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 944,00M | Net Income (TTM) | -381,00M |
| ROE | -70,72% | ROA | -10,81% |
| Gross Margin | 98,31% | Operating Margin | -40,47% |
| Net Margin | -40,36% | Free Cash Flow (TTM) | -320,03M |
| ROIC | -9,23% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 5,35 | Current Ratio | 3,83 |
| Interest Coverage | -5,23 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -30,69 | P/B Ratio | 23,91 |
| P/S Ratio | 12,39 | PEG Ratio | 1,53 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 11,69B | Enterprise Value | 13,94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 944,00M | 705,14M | 787,65M | 587,37M | 810,46M |
| Net Income | -381,00M | -453,90M | -366,29M | -269,72M | -28,60M |
| EPS (Diluted) | -2,38 | -3,04 | -2,56 | -1,90 | -0,20 |
| Gross Profit | 928,00M | 693,92M | 778,51M | 573,25M | 799,61M |
| Operating Income | -382,00M | -475,08M | -353,73M | -410,19M | -30,19M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,52B | 3,00B | 2,99B | 2,53B | 2,61B |
| Total Liabilities | 3,03B | 2,42B | 2,60B | 1,96B | 1,84B |
| Shareholders' Equity | 489,09M | 588,35M | 386,69M | 572,89M | 771,74M |
| Total Debt | 2,61B | 1,42B | 1,45B | 1,37B | 1,25B |
| Cash & Equivalents | 372,26M | 242,08M | 399,27M | 276,47M | 869,19M |
| Current Assets | 2,99B | 2,62B | 2,64B | 2,20B | 2,35B |
| Current Liabilities | 781,57M | 309,32M | 448,09M | 311,56M | 240,55M |